With growing bipartisan support and after debate in both the US House and Senate, Life Science companies recognize the BIOSECURE Act has strong support to pass. If enacted, it will prohibit US Federal Agencies and companies receiving federal funding to work with select Chinese Life Science companies.
Category: Supplier Due Diligence
By leveraging digital tools for supplier onboarding, collaboration and payment, CFOs can improve financial visibility, identify cost-saving opportunities and make informed decisions to optimize financial performance in the rapidly evolving life sciences landscape.
Improving the odds of selecting the right CDMO for your organization requires an evaluation of market analysis, manufacturing and quality assessment, financial discussion, and several other key factors. Both the sponsor and the CDMO need to know they can build strong relationships with people to address complex issues while meeting tight deadlines.
The truth supply chain managers must face is that although the COVID pandemic was unprecedented, the disruptions it caused are not. The pandemic merely exposed supply chain weaknesses that were already there.
How a company structures its procurement and sourcing function will dictate how well it can work with suppliers to meet demanding customer and regulatory requirements.
As an emerging company, does your team have the framework and experience to manage suppliers during major disruptions?
